NCT00048321View on ClinicalTrials.gov

ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 1, 2002

Primary Completion Date

February 1, 2003

Study Completion Date

February 1, 2003

Conditions
Rheumatoid Arthritis
Interventions
DRUG

ISIS 104838

Trial Locations (31)

Unknown

Birmingham

Paradise Valley

Los Angeles

Rancho Cucamonga

Fort Lauderdale

Palm Harbor

Sarasota

Tampa

Decatur

Chicago

Wichita

Louisville

Greenbelt

Fall River

Lansing

St Louis

Albuquerque

Mayfield

Duncansville

Willow Grove

Amarillo

Carrollton

Dallas

Lubbock

Richmond

Seattle

Calgary

Edmonton

Victoria

Ottawa

Toronto

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY